glutathione and triple negative breast cancer Frontiers A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



